Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Milpied

Showing results (21-30 of 240) with videos related to

Pageof 24
Sort By:
Anticancer Research|November 1, 1994
Pharmacokinetics of high-dose melphalan in adults: influence of renal functionM F Kergueris, N Milpied, P Moreau, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1992
Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patientsP Moreau, N Milpied, N Fayette, et al.
Presse Medicale (Paris, France : 1983)|August 3, 1988
[First-line treatment of severe myelomas of the young subject by high-dose melphalan]J L Harousseau, N Milpied, F Guilhot, et al.
Presse Medicale (Paris, France : 1983)|January 23, 1988
[Lethal aplasia after treatment with alpha-interferon of recurrent chronic myeloid leukemia following allogeneic bone marrow graft]J L Harousseau, N Milpied, J H Bourhis, et al.
Medecine Et Maladies Infectieuses|July 20, 2010
[Persistent influenza virus infection in a patient treated with alemtuzumab]S Burrel, S Dilhuydy, K Bouabdallah, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2002
[Autologous peripheral blood selected CD34+ cell transplantation in the treatment of multiple myeloma]X Tang, N Morineau, N Milpied, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow TransplantationN Milpied, A K Fielding, R M Pearce, et al.
Lancet (London, England)|November 5, 1988
Treatment of acute graft-versus-host disease with monoclonal antibody to IL-2 receptorP Hervé, J Wijdenes, J P Bergerat, et al.
Annales De Medecine Interne|January 1, 1983
[Lesions evoking Sweet's syndrome in acute leukemia: occurring during the stage of therapeutic aplasia]N Milpied, J L Harousseau, S Castaigne, et al.
La Revue De Medecine Interne|January 1, 1996
[Fusaria infection in patients with neutropenia: apropos of 3 cases]P Chevalet, M Tiab, M Miegeville, et al.
Pageof 24

Showing results (21-30 of 240) with videos related to

Sort By:
Pageof 24
Anticancer Research|November 1, 1994
Pharmacokinetics of high-dose melphalan in adults: influence of renal functionM F Kergueris, N Milpied, P Moreau, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1992
Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patientsP Moreau, N Milpied, N Fayette, et al.
Presse Medicale (Paris, France : 1983)|August 3, 1988
[First-line treatment of severe myelomas of the young subject by high-dose melphalan]J L Harousseau, N Milpied, F Guilhot, et al.
Presse Medicale (Paris, France : 1983)|January 23, 1988
[Lethal aplasia after treatment with alpha-interferon of recurrent chronic myeloid leukemia following allogeneic bone marrow graft]J L Harousseau, N Milpied, J H Bourhis, et al.
Medecine Et Maladies Infectieuses|July 20, 2010
[Persistent influenza virus infection in a patient treated with alemtuzumab]S Burrel, S Dilhuydy, K Bouabdallah, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 6, 2002
[Autologous peripheral blood selected CD34+ cell transplantation in the treatment of multiple myeloma]X Tang, N Morineau, N Milpied, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow TransplantationN Milpied, A K Fielding, R M Pearce, et al.
Lancet (London, England)|November 5, 1988
Treatment of acute graft-versus-host disease with monoclonal antibody to IL-2 receptorP Hervé, J Wijdenes, J P Bergerat, et al.
Annales De Medecine Interne|January 1, 1983
[Lesions evoking Sweet's syndrome in acute leukemia: occurring during the stage of therapeutic aplasia]N Milpied, J L Harousseau, S Castaigne, et al.
La Revue De Medecine Interne|January 1, 1996
[Fusaria infection in patients with neutropenia: apropos of 3 cases]P Chevalet, M Tiab, M Miegeville, et al.
Pageof 24